Microspheres and nanoparticles used in ocular delivery systems

被引:0
|
作者
Institute of Pharmaceutical Technology, Biocenter, Johann Wolfgang Goethe University, Marie-Curie-Strasse 9, D-60439, Frankfurt am Main, Germany [1 ]
机构
来源
ADV. DRUG DELIV. REV. | / 1卷 / 61-73期
关键词
Colloids - Composition effects - Diseases - Drug products - Drug therapy - Ophthalmology - Particles (particulate matter) - Solubility - Suspensions (fluids) - Vision;
D O I
暂无
中图分类号
学科分类号
摘要
Microparticles and nanoparticles are colloidal drug carriers in the micro- and submicron range. These systems were developed to overcome solubility problems of poorly soluble drugs as well as for long acting injectable depot formulations and specific drug targeting options. These carriers were also evaluated for ophthalmic drug delivery purposes over the past 15 years. The main objective for these systems was to improve the classical aqueous eye drop formulations which have major disadvantages like a rapid elimination of the drugs from the precorneal area. Consequently, colloidal carrier suspensions were designed to combine ophthalmic prolonged action with the ease of the application of liquid eye drops. The review summarizes the present manufacturing methods and the materials used for these delivery systems with respect to ophthalmic purposes. The distribution and penetration pathways of the particulate delivery systems are also described. The applications of drug-loaded particles are presented with focus on ophthalmic diseases like glaucoma, inflammations or infections of the eye. Accordingly, particulate carriers outlined in the review include systems loaded with pilocarpine, beta-blockers, hydrocortisone, amikacin, and miscellaneous drugs. Finally, the biodegradation and toxicity of the carrier materials under evaluation are reviewed.
引用
收藏
相关论文
共 50 条
  • [21] Mucoadhesive Nanoparticles as Carrier Systems for Prolonged Ocular Delivery of Gatifloxacin/Prednisolone Bitherapy
    Ibrahim, Howida Kamal
    El-Leithy, Iman Sadar
    Makky, Amna Awad
    MOLECULAR PHARMACEUTICS, 2010, 7 (02) : 576 - 585
  • [22] Considerations for Polymers Used in Ocular Drug Delivery
    Allyn, Megan M.
    Luo, Richard H.
    Hellwarth, Elle B.
    Swindle-Reilly, Katelyn E.
    FRONTIERS IN MEDICINE, 2022, 8
  • [23] LIPOSOME OCULAR DELIVERY SYSTEMS
    MEISNER, D
    MEZEI, M
    ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (01) : 75 - 93
  • [24] Protein microspheres as delivery systems.
    Kolbeck, KJ
    Wong, M
    Webb, AG
    Suslick, KS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U7 - U7
  • [25] Microspheres as nasal drug delivery systems
    Pereswetoff-Morath, L
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) : 185 - 194
  • [26] POLYANHYDRIDES MICROSPHERES AS DRUG DELIVERY SYSTEMS
    MATHIOWITZ, E
    LANGER, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 72 - PMSE
  • [27] STARCH MICROSPHERES AS DRUG DELIVERY SYSTEMS
    RUSSELL, GFJ
    PHARMACY INTERNATIONAL, 1983, 4 (10): : 260 - 262
  • [28] Carbohydrate Polymers, Polymeric Nano Drugs, and Nanoparticles Are Used for Advanced Drug Delivery and Therapeutics in Ocular Diseases
    Hatamie, Shadie
    Shih, Po-Jen
    Chen, Bo-Wei
    Hatami, Niloofar
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2025, 36 (02)
  • [29] Application of lipid nanoparticles to ocular drug delivery
    Battaglia, Luigi
    Serpe, Loredana
    Foglietta, Federica
    Muntoni, Elisabetta
    Gallarate, Marina
    Del Pozo Rodriguez, Ana
    Angeles Solinis, Maria
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (12) : 1743 - 1757
  • [30] Nanoparticles for ocular surface drug and gene delivery
    Kompella, U. B.
    ACTA OPHTHALMOLOGICA, 2016, 94